Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Hardy

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 26, 2014
Vitamin D deficiency in patients with malignancy in BrisbaneAdam Morton, Janet Hardy, Anthony Morton, et al.
Journal of Blood Medicine|August 22, 2020
Preoperative Anemia Screening and Treatment Practices in Patients Having Total Joint Replacement Surgery: A Retrospective, Observational AuditAlana Delaforce, Lemya Galeel, Edgar Poon, et al.
BMC Palliative Care|December 8, 2019
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)Phillip Good, Alison Haywood, Gauri Gogna, et al.
Clinical Therapeutics|August 23, 2017
Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?Rani George, Alison Haywood, Phillip Good, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2023
Exploring potential anti-inflammatory effects of medicinal cannabisTaylan Gurgenci, Gregor Kijanka, Ristan Greer, et al.
Trials|July 8, 2020
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)Janet Hardy, Alison Haywood, Gauri Gogna, et al.
Australian Health Review : a Publication of the Australian Hospital Association|June 22, 2015
Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trialNikki McCaffrey, Janet Hardy, Belinda Fazekas, et al.
Clinical Therapeutics|September 26, 2015
Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with CancerSudeep R Bista, Alison Haywood, Ross Norris, et al.
Clinical Therapeutics|December 2, 2015
Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with CancerSudeep R Bista, Alison Haywood, Ross Norris, et al.
Palliative Medicine|December 24, 2024
Orally dissolving pilocarpine tablets for xerostomia in advanced cancer: A pilot N-of-1 feasibility studyKaryn Foster, Geoff Mitchell, Evan Richard, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 26, 2014
Vitamin D deficiency in patients with malignancy in BrisbaneAdam Morton, Janet Hardy, Anthony Morton, et al.
Journal of Blood Medicine|August 22, 2020
Preoperative Anemia Screening and Treatment Practices in Patients Having Total Joint Replacement Surgery: A Retrospective, Observational AuditAlana Delaforce, Lemya Galeel, Edgar Poon, et al.
BMC Palliative Care|December 8, 2019
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)Phillip Good, Alison Haywood, Gauri Gogna, et al.
Clinical Therapeutics|August 23, 2017
Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?Rani George, Alison Haywood, Phillip Good, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2023
Exploring potential anti-inflammatory effects of medicinal cannabisTaylan Gurgenci, Gregor Kijanka, Ristan Greer, et al.
Trials|July 8, 2020
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)Janet Hardy, Alison Haywood, Gauri Gogna, et al.
Australian Health Review : a Publication of the Australian Hospital Association|June 22, 2015
Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trialNikki McCaffrey, Janet Hardy, Belinda Fazekas, et al.
Clinical Therapeutics|September 26, 2015
Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with CancerSudeep R Bista, Alison Haywood, Ross Norris, et al.
Clinical Therapeutics|December 2, 2015
Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with CancerSudeep R Bista, Alison Haywood, Ross Norris, et al.
Palliative Medicine|December 24, 2024
Orally dissolving pilocarpine tablets for xerostomia in advanced cancer: A pilot N-of-1 feasibility studyKaryn Foster, Geoff Mitchell, Evan Richard, et al.
Pageof 10